|
Life Sciences
The movement toward new biology-based drug discovery and product development is driving a massive IT infrastructure buildup, which will have a significant impact on the growth of associated IT markets. IDC's Bio-IT Infrastructure service will analyze the convergence between IT and the emerging bioscience market. This service will offer strategic and tactical analysis and advice for infrastructure vendors and suppliers seeking to understand the opportunities developing within this emerging market.
On the right you'll find analysts working on this team. Click on the name of the analyst to view his or her profile. Below is a list of the most recently published research from this team.
New Research
Worldwide Information Access, Analysis, and Management Software 2010 Top 10 Predictions
Susan Feldman, Melissa Webster, Dan Vesset, Caroline Dangson, Henry D. Morris, Brian McDonough
Jan 2010 - Doc # 221579
Top 10 Predictions
This IDC study presents 10 predictions for the information access, analysis, and management software market in 2010. 2010 could well prove to be a seminal year for information access, analysis, and management software market. T ...
purchase document
|
Oracle OpenWorld 2009: Oracle Applications Recap
Michael Fauscette, Albert Pang, Dan Vesset, Tomoko Akagi, Robert P. Mahowald, Henry D. Morris, Elisabeth Rainge, Alan Tong, Rona Shuchat, Sanjeev Pal, Melissa Webster
Dec 2009 - Doc # 221133
Insight
This IDC Insight takes a look at the recent Oracle OpenWorld User and Partner Conference held in San Francisco, California. This annual event, which even in this poor economic climate drew over 40,000 people, previewed new prod ...
purchase document
|
|
|
|
Dan Vesset
Program Vice President, Business Analytics |
|
|
|
